Interpace Biosciencesincis A Leader In The Life Sciences Sectorfocusing On Complex Molecular Analysis For Early Cancer Diagnosis And Treatmentbased In Parsippanynew Jerseythe Company Operates Through Its Subsidiaryinterpace Diagnosticsllcit Evolved From Pdiinc Which Initially Provided Contract Sales Services Before Shifting Its Focus To Diagnostics And Rebranding In 2019 After Acquiring Cancer Geneticsbiopharma Services Division The Company Offers A Variety Of Molecular Diagnostic Tests And Pathology Services Aimed At Assisting Healthcare Providers In Diagnosing And Treating Patientsnotable Products Include Pancragen For Pancreatic Cancer Risk Assessmentthygenext And Thyramir For Evaluating Thyroid Nodulesrespridx For Lung Cancer Riskand Barregen For Assessing Cancer Progression Riskinterpace Biosciences Operates A Clia Certified Clinical Reference Laboratory In Pittsburghpaensuring High Standards In Testing And Analysisthe Company Serves Specialty Physicians And Medical Centers Across The U Sand Internationallyemphasizing Improved Patient Outcomes Through Advanced Diagnostics
No conferences found for this company.
| Company Name | Interpace Diagnostics Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
